8 completed, 3 unknown, 2 recruiting, 1 enrolling by invitation. 7 Phase 4, 4 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 6, Unknown 1 |
| Not applicable | 4 | Unknown 2, Enrolling by invitation 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow HMG: new trials by email Literature Review of HMG trials Research Report on HMG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral Tonsillitis HMG, PHN, PHR - Acute Pharyngitis, Viral Sore Throat | Not applicable | Recruiting | University Hospital, Clermont-Ferrand | 160 | 2026-07-29 | 2026-08-05 |
| Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate - Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes | Not applicable | Enrolling by invitation | Enhanced Emirates Limited | 60 | 2026-03-12 | 2026-05-06 |
| A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) Follitropin alfa/lutropin alfa (MBJ-0011), hMG, Cetrorelix acetate - Infertility | Phase 3 | Recruiting | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 266 | 2026-02-04 | 2026-09-08 |
| Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH) Human Chorionic Gonadotropin, human menopausal gonadotropin - Isolated Hypogonadotropic Hypogonadism, Kallmann Syndrome | Phase 4 | Unknown | Tongji Hospital | 210 | 2018-10-18 | 2020-04-08 |
| Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI induction with aromataze inhibitor, HMG, GnRh a - Infertility Indicated for ICSI | Phase 4 | Completed | Minia University | 50 | 2016-08-12 | 2017-09-06 |
| Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer Letrozole, clomiphene, HMG - Female Infertility Due to Nonimplantation of Ovum | Not applicable | Unknown | Navy General Hospital, Beijing | 100 | 2016-05-01 | 2017-06-23 |
| Miniflare Versus Long Protocol in Poor Responders Triptorelin, Combined oral contraceptive pills, HMG - Infertility | Not applicable | Unknown | Woman's Health University Hospital, Egypt | 200 | 2016-02-01 | 2016-04-04 |
| Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist rFSH, HMG - Infertility | Phase 4 | Completed | Hospital de Clinicas de Porto Alegre | 188 | 2014-01-01 | 2015-08-21 |
| Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization rFSH plus rLH, hMG - Infertility | Completed | University of Turin, Italy | 848 | 2010-03-01 | 2014-12-23 | |
| Gonadotropin Type in Ovarian Stimulation recombinant FSH, Urinary FSH, hMG - Infertility | Phase 4 | Completed | IVI Madrid | 100 | 2009-04-01 | 2015-05-07 |
| MENOPUR® Versus FOLLISTIM® Menotropin, Progestrone vaginal insert, follitropin beta - Infertility | Phase 4 | Completed | Ferring Pharmaceuticals | 173 | 2008-12-01 | 2011-11-02 |
| hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF HMG, rFSH - Polycystic Ovary Syndrome | Phase 4 | Completed | Zekai Tahir Burak Women's Health Research and Education Hospital | 80 | 2008-01-01 | 2012-03-29 |
| A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa Menotrophin, Follitropin alfa - Infertility | Phase 4 | Completed | Ferring Pharmaceuticals | 80 | 2005-10-01 | 2010-02-26 |
| Assessment of the Effectiveness of Menopur in Intrauterine Insemination hMG - Infertility | Completed | Ferring Pharmaceuticals | 207 | 2004-03-01 | 2025-03-28 |
Infertility (9) · Hypogonadism (1) · Kallmann Syndrome (1) · Polycystic Ovary Syndrome (1)
Ferring Pharmaceuticals (3) · Enhanced Emirates Limited (1) · Hospital de Clinicas de Porto Alegre (1) · IVI Madrid (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · Minia University (1) · Navy General Hospital, Beijing (1) · Tongji Hospital (1) · University Hospital, Clermont-Ferrand (1) · University of Turin, Italy (1) · Woman's Health University Hospital, Egypt (1) · Zekai Tahir Burak Women's Health Research and Education Hospital (1)
China (2) · Egypt (2) · Brazil (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Spain (1) · Turkey (Türkiye) (1) · United Arab Emirates (1) · United Kingdom (1) · United States (1)
Aiming Wang, Dr (1) · Alberto Revelli, MD PhD (1) · Antonio Requena, PhD, MD (1) · Dina MR Dakhly, MD (1) · Figen A Turkcapar, MD (1) · Jihong Liu, M.D (1)
PMID 11937133, PMID 16740654, PMID 17110397, PMID 18175787, PMID 24348019, PMID 24520446, PMID 25295506, PMID 39783453
2004 (1)